title: Splenectomy followed by administration of rituximab is useful to treat a patient with hairy cell leukemia-variant.
authors.forename: Tetsumi
authors.initials: T
authors.lastname: Yoshida
authors.forename: Keichiro
authors.initials: K
authors.lastname: Mihara
authors.forename: Sayaka
authors.initials: S
authors.lastname: Sugihara
authors.forename: Koji
authors.initials: K
authors.lastname: Arihiro
authors.forename: Tatsuji
authors.initials: T
authors.lastname: Mino
authors.forename: Naomi
authors.initials: N
authors.lastname: Sasaki
authors.forename: Yoshihiro
authors.initials: Y
authors.lastname: Takihara
mesh_terms: D000368:Aged; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage*; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007943:Leukemia, Hairy Cell / Q000175:diagnosis / Q000188:drug therapy* / Q000601:surgery*; D000069283:Rituximab; D013156:Splenectomy; D016896:Treatment Outcome
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab